əˌzoʊlɪdiːnˈdaɪ.oʊn/, abbreviated as TZD, also known as glitazones after the prototypical drug ciglitazone, are a class of heterocyclic compounds consisting of ...

Nov 27, 2019 · Purpose of Review. Thiazolidinediones (TZDs) are the only pharmacologic agents that specifically treat insulin resistance.

Thiazolidinediones (also called glitazones) are a class of medicines that may be used for the treatment of type 2 diabetes. They are a type of oral ...

Thiazolidinediones act by increasing insulin sensitivity in tissues. They are agonists at the nuclear peroxisome proliferator-activated receptor-γ (PPARγ). PPAR ...

The thiazolidinediones (TZDs) are a group of drugs that increase insulin sensitivity by acting on adipose tissue, muscle, and liver to increase glucose ...

May 26, 2019 · Thiazolidinediones (rosiglitazone, pioglitazone) are oral insulin-sensitizing medications used in type 2 diabetes mellitus that reduce ...

INTRODUCTION. The thiazolidinediones increase insulin sensitivity by acting on adipose, muscle, and, to a lesser extent, liver to increase glucose ...

Thiazolidinediones, also known as glitazones, are a group of oral anti-diabetic drugs designed to treat patients with type 2 diabetes.